TuHURA Biosciences (HURA) Depreciation & Amortization (CF) (2021 - 2026)

TuHURA Biosciences' Depreciation & Amortization (CF) history runs 6 years deep, the most recent figure standing at $23472.0 for Q1 2026.

• On a quarterly basis, Depreciation & Amortization (CF) rose 66.97% year-over-year to $23472.0 in Q1 2026; TTM through Mar 2026 was $80679.0, a 55.93% decrease from a year earlier, with the FY2025 full-year figure at $71265.0, down 38.94% from the prior year.
• Depreciation & Amortization (CF) climbed to $23472.0 in Q1 2026 per HURA's latest filing, from $22544.0 in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $99075.0 in Q3 2024 and bottomed at $13371.0 in Q2 2025.
• The 5-year median for Depreciation & Amortization (CF) is $15000.0 (2022), against an average of $27870.2.
• Across the five-year window, Depreciation & Amortization (CF) surged 560.5% in 2024 and slumped 80.88% in 2025, its largest moves.
• Year by year, Depreciation & Amortization (CF) stood at $15000.0 in 2022, then soared by 100.0% to $30000.0 in 2023, then surged by 230.25% to $99075.0 in 2024, then tumbled by 77.25% to $22544.0 in 2025, then climbed by 4.12% to $23472.0 in 2026.
• Per Business Quant, the three latest HURA Depreciation & Amortization (CF) figures stand at $23472.0 (Q1 2026), $22544.0 (Q4 2025), and $21292.0 (Q3 2025).